Antimicrobial resistance (AMR) kills over a million people each year—and without action, 39 million people could die between now and 2050. The threat isn’t just limited to health: AMR could cost the global economy billions.
To quantify this burden, CGD has developed a new, interactive web tool—which will be launched during the event—that estimates the economic impact of AMR across 122 countries. New research behind the tool finds that both high-income and low- and middle-income countries could add billions to their economies by increasing access to innovative gram-negative antibiotics and improving treatment of AMR.
A key step in achieving these goals is the establishment of an Independent Panel for Evidence on Action Against AMR that generates high-quality evidence that informs policy. This event, held on the sidelines of the World Health Assembly, will draw on new research to explore how the Independent Panel can be structured to effectively address the growing health and economic burden of AMR. Discussion will also focus on how the Independent Panel can ensure equitable representation, both geographically and interdisciplinary, and explore what it can learn from other global panels, to promote scientific independence and secure sustainable funding.
A complimentary reception with drinks and canapes will follow the conversation.
